The disruption of lipid homeostasis in NPC1-deficient cells can influence the metabolism of drugs and other xenobiotics. Since many drugs are lipophilic and rely on normal lipid trafficking for their action and clearance, NPC1 mutations can impair drug distribution and excretion. This can lead to altered pharmacokinetics and increased susceptibility to drug-induced toxicity, necessitating careful consideration in clinical settings.
